{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:26:27Z","timestamp":1790814387125,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cellsig.2020.109804","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:12:02Z","timestamp":1602022322000},"page":"109804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Granzymes in cardiovascular injury and disease"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-5791","authenticated-orcid":false,"given":"Matthew R.","family":"Zeglinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Granville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"265","key":"10.1016\/j.cellsig.2020.109804_bb0005","doi-asserted-by":"crossref","first-page":"265sr6","DOI":"10.1126\/scitranslmed.3009337","article-title":"Wound repair and regeneration: mechanisms, signaling, and translation","volume":"6","author":"Eming","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.jid.5700701","article-title":"Inflammation in wound repair: molecular and cellular mechanisms","volume":"127","author":"Eming","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cvr\/cvs099","article-title":"The role of calpains in myocardial remodelling and heart failure","volume":"96","author":"Letavernier","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jjcc.2009.06.009","article-title":"Plasma granzyme B as a predicting factor of coronary artery disease--clinical significance in patients with chronic renal failure","volume":"54","author":"Ikemoto","year":"2009","journal-title":"J. Cardiol."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109804_bb0030","doi-asserted-by":"crossref","first-page":"e78939","DOI":"10.1371\/journal.pone.0078939","article-title":"Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice","volume":"8","author":"Hiebert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2020.109804_bb0035","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1038\/cddis.2011.88","article-title":"Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm","volume":"2","author":"Ang","year":"2011","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0040","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2353\/ajpath.2010.090700","article-title":"Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm","volume":"176","author":"Chamberlain","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0045","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jid.2018.09.031","article-title":"Granzyme K expressed by classically activated macrophages contributes to inflammation and impaired remodeling","volume":"139","author":"Turner","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0095-0","article-title":"Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing","volume":"50","author":"Shen","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.exger.2011.02.004","article-title":"Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice","volume":"46","author":"Hiebert","year":"2011","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/acel.12298","article-title":"Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation","volume":"14","author":"Parkinson","year":"2015","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/labinvest.2014.62","article-title":"Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability","volume":"94","author":"Hendel","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cellsig.2020.109804_bb0070","article-title":"Granzyme B Contributes to barrier dysfunction in oxazolone-induced skin inflammation through E-Cadherin and FLG cleavage","author":"Turner","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0075","first-page":"4133","article-title":"Maternal diesel particle exposure promotes offspring asthma through NK cell-derived granzyme B","volume":"130","author":"Qian","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107847","article-title":"Extracellular granzyme a promotes colorectal cancer development by enhancing gut inflammation","volume":"32","author":"Santiago","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.shk.0000246905.24895.e5","article-title":"Altered levels and molecular forms of granzyme k in plasma from septic patients","volume":"27","author":"Rucevic","year":"2007","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.chembiol.2005.03.006","article-title":"Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells","volume":"12","author":"Mahrus","year":"2005","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0095","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1074\/jbc.M806716200","article-title":"Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A","volume":"284","author":"Bovenschen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0100","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1021\/pr500968d","article-title":"Substrate specificities of the granzyme tryptases A and K","volume":"13","author":"Plasman","year":"2014","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4049\/jimmunol.1101381","article-title":"Structural insights into the substrate specificity of human granzyme H: the functional roles of a novel RKR motif","volume":"188","author":"Wang","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02602778","article-title":"Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1","volume":"44","author":"Kelly","year":"1996","journal-title":"Immunogenetics"},{"issue":"52","key":"10.1016\/j.cellsig.2020.109804_bb0115","doi-asserted-by":"crossref","first-page":"54275","DOI":"10.1074\/jbc.M411482200","article-title":"Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B","volume":"279","author":"Mahrus","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109804_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","article-title":"Death by a thousand cuts: granzyme pathways of programmed cell death","volume":"26","author":"Chowdhury","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.immuni.2009.03.016","article-title":"The molecular basis for perforin oligomerization and transmembrane pore assembly","volume":"30","author":"Baran","year":"2009","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cellsig.2020.109804_bb0130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","article-title":"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma","volume":"89","author":"Boivin","year":"2009","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/eji.1830250432","article-title":"Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway","volume":"25","author":"Isaaz","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/icb.2008.98","article-title":"Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement","volume":"87","author":"Prakash","year":"2009","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2007.05.004","article-title":"Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis","volume":"111","author":"Kim","year":"2007","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109804_bb0150","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/sj.cdd.4402183","article-title":"Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin","volume":"14","author":"Pardo","year":"2007","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.cellsig.2020.109804_bb0155","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.molimm.2007.03.024","article-title":"Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation","volume":"44","author":"Strik","year":"2007","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41467-017-00327-8","article-title":"Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B","volume":"8","author":"Wroblewski","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0165","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood-2003-10-3708","article-title":"Granzyme A: an additional weapon of human polymorphonuclear neutrophils (PMNs) in innate immunity?","volume":"103","author":"Hochegger","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0170","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood-2003-04-1069","article-title":"Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0175","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0180","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.4049\/jimmunol.0901066","article-title":"Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21","volume":"183","author":"Hagn","year":"2009","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.cellsig.2020.109804_bb0185","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1182\/blood-2012-08-452995","article-title":"IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation","volume":"121","author":"Karrich","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0190","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2006-03-010348","article-title":"Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma","volume":"108","author":"Tschopp","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0195","first-page":"1799","article-title":"Expression of granzyme B in human articular chondrocytes","volume":"30","author":"Horiuchi","year":"2003","journal-title":"J. Rheumatol."},{"issue":"19","key":"10.1016\/j.cellsig.2020.109804_bb0200","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1074\/jbc.M512694200","article-title":"Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin","volume":"281","author":"Hernandez-Pigeon","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109804_bb0205","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1074\/jbc.M607436200","article-title":"UVA induces granzyme B in human keratinocytes through MIF: implication in extracellular matrix remodeling","volume":"282","author":"Hernandez-Pigeon","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109804_bb0210","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.4049\/jimmunol.159.11.5293","article-title":"Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense","volume":"159","author":"Berthou","year":"1997","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0215","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1095\/biolreprod.104.030452","article-title":"Granzyme N, a novel granzyme, is expressed in spermatocytes and spermatids of the mouse testis","volume":"71","author":"Takano","year":"2004","journal-title":"Biol. Reprod."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0220","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/rccm.200602-169OC","article-title":"Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease","volume":"175","author":"Vernooy","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"14","key":"10.1016\/j.cellsig.2020.109804_bb0225","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","article-title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack","volume":"121","author":"Lopez","year":"2013","journal-title":"Blood"},{"issue":"46","key":"10.1016\/j.cellsig.2020.109804_bb0230","doi-asserted-by":"crossref","first-page":"29073","DOI":"10.1074\/jbc.271.46.29073","article-title":"New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis","volume":"271","author":"Froelich","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6475","key":"10.1016\/j.cellsig.2020.109804_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"Kagi","year":"1994","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14728222.2019.1661380","article-title":"Granzyme B as a therapeutic target for wound healing","volume":"23","author":"Turner","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0245","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.4049\/jimmunol.174.9.5456","article-title":"Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis","volume":"174","author":"Shi","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109804_bb0250","doi-asserted-by":"crossref","first-page":"e1458","DOI":"10.1038\/cddis.2014.423","article-title":"Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing","volume":"5","author":"Hsu","year":"2014","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.celrep.2014.06.012","article-title":"Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis","volume":"8","author":"Arias","year":"2014","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0260","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.4049\/jimmunol.1000430","article-title":"A role for granzyme M in TLR4-driven inflammation and endotoxicosis","volume":"185","author":"Anthony","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109804_bb0265","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/cddiscovery.2016.84","article-title":"Granzymes A and K differentially potentiate LPS-induced cytokine response","volume":"2","author":"Wensink","year":"2016","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0270","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.39857","article-title":"Granzyme A contributes to inflammatory arthritis in mice through stimulation of osteoclastogenesis","volume":"69","author":"Santiago","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0275","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2249.1999.00881.x","article-title":"The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)","volume":"116","author":"Tak","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/hrt.2006.110023","article-title":"Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome","volume":"94","author":"Tsuru","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.cellsig.2020.109804_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/343268","article-title":"Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine","volume":"2013","author":"El-Mesallamy","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajpath.2015.09.010","article-title":"Granzyme B deficiency protects against angiotensin II-induced cardiac fibrosis","volume":"186","author":"Shen","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0295","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1253\/circj.CJ-08-0668","article-title":"Elevation of plasma granzyme B levels after acute myocardial infarction","volume":"73","author":"Kondo","year":"2009","journal-title":"Circ. J."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0300","doi-asserted-by":"crossref","first-page":"e21484","DOI":"10.1371\/journal.pone.0021484","article-title":"Granzyme K activates protease-activated receptor-1","volume":"6","author":"Cooper","year":"2011","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.cellsig.2020.109804_bb0305","doi-asserted-by":"crossref","first-page":"23549","DOI":"10.1074\/jbc.M412001200","article-title":"Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin","volume":"280","author":"Buzza","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0310","doi-asserted-by":"crossref","first-page":"e33163","DOI":"10.1371\/journal.pone.0033163","article-title":"Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-beta1","volume":"7","author":"Boivin","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0315","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCULATIONAHA.113.005457","article-title":"Aneurysm global epidemiology study","volume":"129","author":"Sidloff","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0320","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157016111301150303132348","article-title":"Inflammaging and proteases in abdominal aortic aneurysm","volume":"13","author":"Hendel","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/jmbi.1996.0237","article-title":"Fibrillin-1: organization in microfibrils and structural properties","volume":"258","author":"Reinhardt","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"4\u20135","key":"10.1016\/j.cellsig.2020.109804_bb0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1025383913444","article-title":"The role of decorin in collagen fibrillogenesis and skin homeostasis","volume":"19","author":"Reed","year":"2002","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0335","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1679\/aohc.71.37","article-title":"The modulation of collagen fibril assembly and its structure by decorin: an electron microscopic study","volume":"71","author":"Iwasaki","year":"2008","journal-title":"Arch. Histol. Cytol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0340","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1083\/jcb.136.3.729","article-title":"Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility","volume":"136","author":"Danielson","year":"1997","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0345","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1524-475X.2011.00677.x","article-title":"Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar","volume":"19","author":"Honardoust","year":"2011","journal-title":"Wound Repair Regen."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0350","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1038\/s41598-017-16194-8","article-title":"Recombinant decorin fusion protein attenuates murine abdominal aortic aneurysm formation and rupture","volume":"7","author":"Shen","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0355","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.atherosclerosis.2007.05.001","article-title":"Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity","volume":"195","author":"Skjelland","year":"2007","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.MP.0000067424.12280.BC","article-title":"Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity","volume":"16","author":"Choy","year":"2003","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0365","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1053-2498(02)00498-9","article-title":"The registry of the international society for heart and lung transplantation: nineteenth official report-2002","volume":"21","author":"Hertz","year":"2002","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0370","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can. J. Surg."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0375","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","article-title":"Allograft vasculopathy versus atherosclerosis","volume":"99","author":"Rahmani","year":"2006","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0380","first-page":"400","article-title":"Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation","volume":"40","author":"Segura","year":"2013","journal-title":"Tex. Heart Inst. J."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0385","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00007890-200104270-00023","article-title":"CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model","volume":"71","author":"Fischbein","year":"2001","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0390","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0003-4975(97)00796-0","article-title":"Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy","volume":"64","author":"Allan","year":"1997","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0002-9440(10)63281-6","article-title":"Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts","volume":"165","author":"Choy","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0400","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-6143.2004.00710.x","article-title":"Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease","volume":"5","author":"Choy","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"17","key":"10.1016\/j.cellsig.2020.109804_bb0405","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"A scientific statement for health professionals From the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0410","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0031-3955(05)70120-6","article-title":"Kawasaki syndrome","volume":"46","author":"Rowley","year":"1999","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.cellsig.2020.109804_bb0415","article-title":"Histologic and immunohistochemical evaluation of infiltrating inflammatory cells in Kawasaki Disease Arteritis Lesions","author":"Kobayashi","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"6 Suppl","key":"10.1016\/j.cellsig.2020.109804_bb0420","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1007\/BF01540888","article-title":"The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome","volume":"15","author":"Leung","year":"1995","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/intimm\/dxg007","article-title":"Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease","volume":"15","author":"Duong","year":"2003","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0430","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/323155","article-title":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease","volume":"184","author":"Brown","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0435","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1542\/peds.112.4.986","article-title":"Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect","volume":"112","author":"Kuijpers","year":"2003","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0440","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.inf.0000157224.25722.76","article-title":"CD8 T lymphocytes do not express cytotoxic proteins in coronary artery aneurysms in acute Kawasaki disease","volume":"24","author":"Guzman-Cottrill","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12865-020-00348-x","article-title":"Increased Interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease","volume":"21","author":"Xing","year":"2020","journal-title":"BMC Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0450","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pharmthera.2011.01.003","article-title":"Structure, function and pathophysiology of protease activated receptors","volume":"130","author":"Adams","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0455","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/iub.441","article-title":"Protease-activated receptors and myocardial infarction","volume":"63","author":"Antoniak","year":"2011","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12079-011-0146-y","article-title":"Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2)","volume":"6","author":"Murray","year":"2012","journal-title":"J Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0465","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1582-4934.2005.tb00501.x","article-title":"Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure","volume":"9","author":"Moshal","year":"2005","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109804_bb0470","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/ATVBAHA.110.213280","article-title":"Protease-activated receptor 2 deficiency reduces cardiac ischemia\/reperfusion injury","volume":"30","author":"Antoniak","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0475","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10517-007-0425-z","article-title":"Proteinase-activated receptor agonists stimulate the increase in intracellular Ca2+ in cardiomyocytes and proliferation of cardiac fibroblasts from chick embryos","volume":"144","author":"Ide","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0480","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/HYPERTENSIONAHA.111.169417","article-title":"Tryptase\/protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts","volume":"58","author":"McLarty","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0485","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-017-0901-y","article-title":"Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1beta","volume":"14","author":"Lee","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"17","key":"10.1016\/j.cellsig.2020.109804_bb0490","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1073\/pnas.91.17.8112","article-title":"Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes","volume":"91","author":"Suidan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.cellsig.2020.109804_bb0495","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1073\/pnas.0409535102","article-title":"A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis","volume":"102","author":"Hansen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0500","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/febs.13699","article-title":"Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0505","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.RES.0000246849.17887.66","article-title":"Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor\/matrix protein synergism","volume":"99","author":"Wijelath","year":"2006","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0510","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.200409115","article-title":"Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors","volume":"169","author":"Lee","year":"2005","journal-title":"J. Cell Biol."},{"issue":"36","key":"10.1016\/j.cellsig.2020.109804_bb0515","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","article-title":"Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms","volume":"267","author":"Houck","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0520","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.healun.2012.09.030","article-title":"VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients","volume":"32","author":"Daly","year":"2013","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0525","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2016.09.013","article-title":"Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients","volume":"36","author":"Daly","year":"2017","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0530","doi-asserted-by":"crossref","first-page":"H1507","DOI":"10.1152\/ajpheart.2000.278.5.H1507","article-title":"Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits","volume":"278","author":"Golino","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0535","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)64824-9","article-title":"Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation","volume":"157","author":"Erlich","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"24","key":"10.1016\/j.cellsig.2020.109804_bb0540","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0545","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1096\/fasebj.7.2.8440408","article-title":"von Willebrand factor","volume":"7","author":"Ruggeri","year":"1993","journal-title":"FASEB J."},{"issue":"33","key":"10.1016\/j.cellsig.2020.109804_bb0550","doi-asserted-by":"crossref","first-page":"22498","DOI":"10.1074\/jbc.M709080200","article-title":"Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor","volume":"283","author":"Buzza","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0555","doi-asserted-by":"crossref","first-page":"e24216","DOI":"10.1371\/journal.pone.0024216","article-title":"Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity","volume":"6","author":"Hollestelle","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0560","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbadis.2012.12.013","article-title":"Coagulation and coagulation signalling in fibrosis","volume":"1832","author":"Mercer","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"13","key":"10.1016\/j.cellsig.2020.109804_bb0565","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1016\/S0021-9258(17)36896-5","article-title":"Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase)","volume":"269","author":"Stack","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2020.109804_bb0570","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0014-5793(92)80339-I","article-title":"Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L","volume":"297","author":"Goretzki","year":"1992","journal-title":"FEBS Lett."},{"issue":"4\u20136","key":"10.1016\/j.cellsig.2020.109804_bb0575","first-page":"731","article-title":"Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer","volume":"50","author":"Schmitt","year":"1991","journal-title":"Biomed. Biochim. Acta"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0580","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-5793(90)80087-Y","article-title":"Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1","volume":"260","author":"Brunner","year":"1990","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0585","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","article-title":"Matrix metalloproteinases generate angiostatin: effects on neovascularization","volume":"161","author":"Cornelius","year":"1998","journal-title":"J. Immunol."},{"issue":"46","key":"10.1016\/j.cellsig.2020.109804_bb0590","doi-asserted-by":"crossref","first-page":"28823","DOI":"10.1074\/jbc.272.46.28823","article-title":"Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B\/type IV collagenase (MMP-9)","volume":"272","author":"Patterson","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0595","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/TA.0000000000001685","article-title":"Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin","volume":"83","author":"Barrett","year":"2017","journal-title":"J. Trauma Acute Care Surg."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0600","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6692167","article-title":"Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen","volume":"81","author":"Heidtmann","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0605","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1515\/BC.2004.061","article-title":"Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation\/inactivation","volume":"385","author":"Bayes","year":"2004","journal-title":"Biol. Chem."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109804_bb0610","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/art.22861","article-title":"Antiangiogenic plasma activity in patients with systemic sclerosis","volume":"56","author":"Mulligan-Kehoe","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0615","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1101\/gr.147800","article-title":"Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function","volume":"10","author":"Irving","year":"2000","journal-title":"Genome Res."},{"issue":"D1","key":"10.1016\/j.cellsig.2020.109804_bb0620","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109804_bb0625","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmed.2019.00025","article-title":"SERPINs-From Trap to Treatment","volume":"6","author":"Sanrattana","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"45","key":"10.1016\/j.cellsig.2020.109804_bb0630","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1021\/acs.biochem.5b01042","article-title":"SERPINB12 Is a Slow-binding inhibitor of granzyme A and Hepsin","volume":"54","author":"Niehaus","year":"2015","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0635","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4049\/jimmunol.1202542","article-title":"Identification of SERPINB1 as a physiological inhibitor of human granzyme H","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0640","doi-asserted-by":"crossref","first-page":"e22645","DOI":"10.1371\/journal.pone.0022645","article-title":"Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death","volume":"6","author":"de Koning","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0645","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/cimm.2001.1806","article-title":"The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses","volume":"210","author":"Buzza","year":"2001","journal-title":"Cell. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109804_bb0650","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/MCB.18.11.6387","article-title":"Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway","volume":"18","author":"Bird","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109804_bb0655","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.166.5.3218","article-title":"The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites","volume":"166","author":"Bladergroen","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109804_bb0660","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.4049\/jimmunol.165.7.3966","article-title":"Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors","volume":"165","author":"Tremblay","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0665","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.191.9.1535","article-title":"The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells","volume":"191","author":"Young","year":"2000","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0670","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.carpath.2010.12.002","article-title":"Proteinase inhibitor 9 is reduced in human atherosclerotic lesion development","volume":"21","author":"Hendel","year":"2012","journal-title":"Cardiovasc. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0675","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/protein\/gzu052","article-title":"Design and characterization of a novel human Granzyme B inhibitor","volume":"28","author":"Marcet-Palacios","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0680","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0161-5890(88)90043-0","article-title":"Inhibition of lymphocyte protease granzyme A by antithrombin III","volume":"25","author":"Masson","year":"1988","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0685","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.ATV.16.3.357","article-title":"Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris","volume":"16","author":"Thompson","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0690","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ajcp\/65.1.64","article-title":"Serum antithrombin in coronary-artery disease","volume":"65","author":"Innerfield","year":"1976","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109804_bb0695","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0049-3848(86)90105-2","article-title":"Protein C and antithrombin III in acute myocardial infarction","volume":"43","author":"Gonzalez","year":"1986","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cellsig.2020.109804_bb0700","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2018.01.014","article-title":"Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age","volume":"269","author":"Croles","year":"2018","journal-title":"Atherosclerosis"},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2020.109804_bb0705","first-page":"1","article-title":"The inter-alpha-inhibitor family: from structure to regulation","volume":"315","author":"Salier","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2020.109804_bb0710","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijdevneu.2017.10.008","article-title":"Alterations in inter-alpha inhibitor protein expression after hypoxic-ischemic brain injury in neonatal rats","volume":"65","author":"Disdier","year":"2018","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.cellsig.2020.109804_bb0715","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.expneurol.2014.07.012","article-title":"Effects of inter-alpha inhibitor proteins on neonatal brain injury: age, task and treatment dependent neurobehavioral outcomes","volume":"261","author":"Threlkeld","year":"2014","journal-title":"Exp. Neurol."},{"issue":"38","key":"10.1016\/j.cellsig.2020.109804_bb0720","doi-asserted-by":"crossref","first-page":"27331","DOI":"10.1074\/jbc.274.38.27331","article-title":"Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma","volume":"274","author":"Wilharm","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.cellsig.2020.109804_bb0725","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0960-894X(02)00363-3","article-title":"Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis","volume":"12","author":"Willoughby","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109804_bb0730","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41551-019-0358-7","article-title":"Non-invasive early detection of acute transplant rejection via nanosensors of granzyme B activity","volume":"3","author":"Mac","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109804_bb0735","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/0008-5472.CAN-16-3346","article-title":"Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response","volume":"77","author":"Larimer","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0740","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.1830230144","article-title":"Charge-dependent binding of granzyme A (MTSP-1) to basement membranes","volume":"23","author":"Vettel","year":"1993","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109804_bb0745","first-page":"219","article-title":"Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase","volume":"60","author":"Simon","year":"1987","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0750","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.4049\/jimmunol.151.12.7161","article-title":"Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes","volume":"151","author":"Froelich","year":"1993","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0755","first-page":"117","article-title":"Mouse T-cell associated serine proteinase 1 degrades collagen type IV: a structural basis for the migration of lymphocytes through vascular basement membranes","volume":"73","author":"Simon","year":"1991","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0760","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41598-018-28070-0","article-title":"Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction","volume":"8","author":"Russo","year":"2018","journal-title":"Sci. Rep."},{"issue":"Suppl","key":"10.1016\/j.cellsig.2020.109804_bb0765","first-page":"107","article-title":"Release of biologically active fragments from human plasma-fibronectin by murine T cell-specific proteinase 1 (TSP-1)","volume":"369","author":"Simon","year":"1988","journal-title":"Biol. Chem. Hoppe Seyler"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109804_bb0770","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.matbio.2012.11.013","article-title":"Granzyme B cleavage of fibronectin disrupts endothelial cell adhesion, migration and capillary tube formation","volume":"32","author":"Hendel","year":"2013","journal-title":"Matrix Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109804_bb0775","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/01.ATV.0000147162.51930.b7","article-title":"Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation","volume":"24","author":"Choy","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109804_bb0780","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4049\/jimmunol.166.3.1433","article-title":"Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation","volume":"166","author":"Gahring","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109804_bb0785","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2008.04.041","article-title":"Granzyme B: evidence for a role in the origin of myasthenia gravis","volume":"201-202","author":"Casciola-Rosen","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109804_bb0790","doi-asserted-by":"crossref","first-page":"e43950","DOI":"10.1371\/journal.pone.0043950","article-title":"Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820302813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820302813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:02:57Z","timestamp":1760266977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820302813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":158,"alternative-id":["S0898656820302813"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109804","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granzymes in cardiovascular injury and disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109804"}}